Mind Medicine (MindMed) Inc. (MNMD) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Mind Medicine (MindMed) Inc. (MNMD:NASDAQ), powered by AI.

Current Price
$24.16
Sector
Healthcare
What is the Mind Medicine (MindMed) Inc. stock price forecast?

Mind Medicine (MindMed) Inc. is currently trading at $24.16. View real-time AI analysis on Alpha Lenz.

What is Mind Medicine (MindMed) Inc. insider trading activity?

View the latest insider trading data for Mind Medicine (MindMed) Inc. on Alpha Lenz.

What is Mind Medicine (MindMed) Inc.'s P/E ratio?

View Mind Medicine (MindMed) Inc.'s valuation metrics on Alpha Lenz.

Mind Medicine (MindMed) Inc.

NASDAQ · MNMD
$24.16+0.39(+1.64%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Mind Medicine (MindMed) Inc.'s future dividend policy...
Alpha Chat Insight

Mind Medicine (MindMed) Inc.'s ROE is -64.1%. Explore profitability and growth together.

Ask for details

Company Overview

Mind Medicine (MindMed) Inc. is a biopharmaceutical company focused on developing psychedelic-inspired medicines and therapies. The primary purpose of MindMed is to innovate treatments for mental health disorders such as anxiety, ADHD, depression, and addiction. By leveraging substances like LSD and psilocybin, the company aims to pioneer new approaches within psychiatric and neurological health sectors. MindMed is at the forefront of integrating psychedelic research into mainstream medical practices, contributing to a growing field exploring non-traditional treatment options. With ongoing clinical trials and significant advancements in its drug development pipeline, MindMed plays a vital role in the shift towards alternative mental health solutions. The company's efforts align with a broader movement in the healthcare industry seeking to destigmatize and scientifically validate the use of psychedelics as viable therapeutic options, positioning itself as a key player in the evolution of psychiatric care.

CEOMr. Robert Barrow
SectorHealthcare
IndustryBiotechnology
Employees74

Company Statistics

FY 2025

Profile

N/AMarket Cap
$0.00Revenue
0.00Shares Out
74Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-49.52%ROA
-64.06%ROE
-48.05%ROIC

Financial Health

$257.84MCash & Cash Equivalents
$-150.06MNet Debt
32.43%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Mind Medicine (MindMed) Inc. (ticker: MNMD) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 74 employees.

The current price is $24.16 with a P/E ratio of -x and P/B of -x.

ROE is -64.06%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Mind Medicine (MindMed) Inc. (MNMD) Stock Forecast 2026 $24.16 — Price, Financials & Analyst Targets | Alpha Lenz